How much funding has PRESAGE BIOSCIENCES, INC. raised?

PRESAGE BIOSCIENCES, INC. has raised $19.0M in total funding, most recently a corporate round round.

Who are PRESAGE BIOSCIENCES, INC.'s investors?

PRESAGE BIOSCIENCES, INC.'s investors include Celgene Corp, Takeda (JP), Bristol Myers Squibb.

When was PRESAGE BIOSCIENCES, INC. founded?

PRESAGE BIOSCIENCES, INC. was founded in 2016.

Where is PRESAGE BIOSCIENCES, INC. headquartered?

PRESAGE BIOSCIENCES, INC. is headquartered in Seattle, Washington, United States.

What industry is PRESAGE BIOSCIENCES, INC. in?

PRESAGE BIOSCIENCES, INC. operates in Biotech, Healthcare.

PRESAGE BIOSCIENCES, INC.

A Pioneer In Translational Oncology

Seattle, United States · Founded 2016 · $19.0M raised

Biotech

Healthcare

Headquarters: Seattle, Washington
Founded: 2016
Business Model: B2B
Website: presagebio.com

Total Funding: $19.0M
Last Round: $13.0M Corporate RoundMar 2021
Rounds: 2

About

Presage Biosciences is a translational oncology company pioneering the CIVO platform, which delivers microdoses of multiple drug candidates simultaneously into living tumors to evaluate their effectiveness in situ. This in vivo approach captures the patient's own immune system and tumor microenvironment to generate more predictive data for cancer drug development. Presage collaborates with pharmaceutical partners to accelerate oncology drug discovery.

Summary

PRESAGE BIOSCIENCES, INC. is a Biotech company based in Seattle, United States, founded in 2016. It has raised $19.0M in total across 2 rounds, most recently a $13.0M Corporate Round round in Mar 2021. Investors include Celgene Corp, Takeda (JP) and Bristol Myers Squibb.